| Name: |
I.M.M. (Ingrid) van Haelst, PharmD |
| Function: |
Hospital Pharmacist and PhD student |
| Department: |
Anesthesiology |
| Division: |
Division of Anesthesiology, Intensive Care and Emergency Medicine |
| E-mail address: |
I.M.M.vanHaelst@umcutrecht.nl |
| Phone number: |
+31 (0) 72 548 3565 |
| Fax number: |
+31 (0) 72 548 2155 |
| Visiting address: |
UMC Utrecht
Heidelberglaan 100
3584 CX Utrecht
The Netherlands |
| Correspondence: |
MCA Alkmaar
P.O. Box 501
1815 JD Alkmaar
The Netherlands |
About Ingrid van Haelst works as a hospital pharmacist at the Clinical Pharmacy of the Medical Center Alkmaar. In July 2008 she started as a PhD student at the department of Clinical Pharmacy and the department of Anesthesiology of the UMC Utrecht. Her PhD thesis concerns medication safety in the perioperative period. Promoters: prof. A.C.G. Egberts, PharmD and prof. C.J. Kalkman, MD. Co-promoter: W.A. van Klei, MD, PhD. Associate researcher. H.J. Doodeman, MsC.
Interest and focus
Ingrid van Haelst’s research interest is perioperative medication safety. Medication use in the perioperative period is a complex issue. Patients admitted for surgical procedures may be receiving a variety of medications for the treatment of acute or chronic conditions. Discontinuation of longstanding medication may be problematic in controlling underlying disease and may also lead to the development of withdrawal symptoms. Most medications are tolerated well through surgery and do not interfere with anesthetic administration. However, continuation of medication during anesthesia may influence hemodynamic parameters or blood loss during surgery.
She has studied the association between the perioperative use of serotonergic antidepressants and the amount of blood loss during surgery and perioperative transfusion requirements. She is currently studying the possible effect of selective serotonin reuptake inhibitors on intraoperative blood pressure and the risk of intraoperative hemodynamic events while monoamine oxidase inhibitors were continued during anesthesia. Another current project focuses on the effect of a preoperative erythropoietin protocol on allogeneic blood transfusion in patients undergoing total hip arthroplasty.